Biblio Discovery — Demo Discovery Service

2 hasil untuk "the Nirsevimab Effectiveness Study Collaborators"

Menampilkan 1–2 · 0,53 detik · RSS

  1. Artikel Jurnal

    Two-season effectiveness of a single nirsevimab dose against RSV hospitalisation in healthy term-born infants: a population-based case–control study, Spain, October 2023 to March 2025

    the Nirsevimab Effectiveness Study Collaborators

    Eurosurveillance, Vol. 31 No. 9 · 2026 · Inggris · DOAJ Scopus

    BACKGROUND In autumn 2023, Spain recommended nirsevimab to all infants born after 1 April 2023, as catch-up or at-birth immunisation. AIM We estimated effectiveness of a single nirsevimab dose against respiratory syncytial virus (RSV) hospitalisations throughout two seasons in healthy term-born…